Medical News

RSS

Commonly used type of bone marrow stem cell may help treat sepsis, new study suggests

A new study from researchers in Ottawa and Toronto suggests that a commonly used type of bone marrow stem cell may be able to help treat sepsis, a deadly condition that can occur when an infection spreads throughout the body. The study, published in the American Journal of Respiratory and Critical Care Medicine, shows that these cells can triple survival rates in an experimental model of sepsis.

1 Jul 2010

Highly specific assay developed to detect ERG alterations in prostate cancer

Researchers at the Uniformed Services University of the Health Sciences Center for Prostate Disease Research, in collaboration with investigators at the Armed Forces Institute of Pathology and Walter Reed Army Medical Center, have developed a highly specific assay for the detection of ERG, a protein associated with tumor formations which is present in more than half of all prostate cancers.

1 Jul 2010

Celsis IVT files patent infringement lawsuit against Invitrogen, CellzDirect

Celsis In Vitro, Inc. announced today that it has filed a patent infringement lawsuit against Invitrogen Corporation and CellzDirect, Inc. in the United States District Court for the Northern District of Illinois in Chicago and has moved for a preliminary injunction. Invitrogen, the parent of CellzDirect, is itself a wholly-owned subsidiary of Life Technologies of Carlsbad, California.

1 Jul 2010

FnBP is central to bacteria's ability to invade organs: Researchers

Scientists studying the so-called "superbug" MRSA have identified one of the components responsible for making it so deadly. Staphylococcus aureus is a type of bacteria commonly found on the skin that is relatively harmless unless it gets into the bloodstream, where it can cause blood poisoning and create abscesses in organs such as the heart and brain.

1 Jul 2010

Mass. reports on people who buy insurance only when sick; Wash. board considers aiding consumers get 'Plan B' referrals; ACLU sues R.I. over electronic records

The Boston Globe: "The number of people who appear to be gaming the state's health insurance system by purchasing coverage only when they are sick quadrupled from 2006 to 2008, according to a long-awaited report released yesterday from the Massachusetts Division of Insurance. The result is that insured residents of Massachusetts wind up paying more for health care, according to the report. … The report was released as state lawmakers consider proposals to make it harder for consumers to jump in and then dump their health insurance coverage" (Lazar, 6/30).

1 Jul 2010

PIKAMAB secures exclusive rights to issued U.S. patent from UABRF

PIKAMAB, a biopharmaceutical company specializing in stratified medicine, announced today that it has secured exclusive rights to an issued U.S. patent (US 6,986,987) from the UAB Research Foundation. This patent pertains to the discovery that the functional polymorphism (Ser/Gly248) in the cytoplasmic domain of Fc alpha receptor determines the proinflammatory potential of serum IgA autoantibodies through cell signaling and production of cytokines such as TNF-alpha, IL-6, and IL-1β in an allele-dependent manner.

1 Jul 2010

New research identifies memory and brain scan as best tests for predicting Alzheimer's disease

New research has identified the memory and brain scan tests that appear to predict best whether a person with cognitive problems might develop Alzheimer's disease. The research is published in the June 30, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology.

1 Jul 2010

Secondhand smoke exposure during pregnancy causes permanent genetic damage in newborns

Newborns of non-smoking moms exposed to secondhand smoke during pregnancy have genetic mutations that may affect long-term health, according to a University of Pittsburgh Graduate School of Public Health study published online in the Open Pediatric Medicine Journal. The abnormalities, which were indistinguishable from those found in newborns of mothers who were active smokers, may affect survival, birth weight and lifelong susceptibility to diseases like cancer.

1 Jul 2010

Twelve residents receive one-year fellowship grant to study medical dermatology

Twelve dermatology residents from leading medical schools around the country each received a $40,000, one-year fellowship grant to study medical dermatology. The fellowships, awarded by the National Psoriasis Foundation, provide support to eligible institutions to develop and enhance opportunities for physicians training for careers in medical dermatology.

1 Jul 2010

Endo responds to FDA Complete Response letter for FORTESTA NDA

Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with low testosterone (Low T), also known as hypogonadism. The FDA's review period for Class 2 resubmissions typically is six months.

1 Jul 2010

Eisai to commercialize lorcaserin for obesity and weight management in U.S.

Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.

1 Jul 2010

Advancements in total hip replacement procedure make young patients opt for surgery

Traditionally, total hip replacement surgery was performed on the elderly, but these days, advancements in the procedure have patients opting for the surgery much earlier in life.

1 Jul 2010

New guide to get pregnant

Infertility affects about 7 million Americans -- that's about one in six couples during their childbearing years. There are many reasons for infertility, with equal chances it's his medical issue as it is hers. A new book, "A Baby at Last!: The Couples' Complete Guide to Getting Pregnant" (Fireside Books, Simon and Schuster), points the way for couples to get past the emotionally wrenching obstacle of infertility and finally bring home their bundle of joy.

1 Jul 2010

Women in early recovery gain new perspective on helping themselves by helping others

Women seeking to overcome an eating disorder or addiction still face numerous hurdles once they acknowledge their disease and commit to pursuing a path of recovery. Women with advanced or multiple interconnected diseases often seek inpatient or residential treatment, which gives them time to step back from the demands of daily life to focus solely on themselves.

1 Jul 2010

Gore receives European CE Mark approval for 25 cm GORE VIABAHN Endoprosthesis

W. L. Gore & Associates today announced that it has received European CE Mark approval for the 25 cm GORE VIABAHN Endoprosthesis with PROPATEN Bioactive Surface. The new 25 cm GORE VIABAHN Endoprosthesis with PROPATEN Bioactive Surface is the longest length stent-graft available, designed to cover more of the lesion in the Superficial Femoral Artery potentially reducing the need for multiple devices.

1 Jul 2010

Eisai signs agreement with Arena Pharmaceuticals GmbH to commercialize lorcaserin

Eisai Inc., the U.S. pharmaceutical operation of Tokyo-based Eisai Co., Ltd., announced today that it has entered into an agreement with Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., for exclusive U.S. rights to commercialize lorcaserin, a drug candidate for potential use in the treatment of obesity, including weight loss, for patients who are obese (Body Mass Index or BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related co-morbid condition.

1 Jul 2010

Community-based lymphatic filariasis education increases treatment compliance up to 90%: Study

Community-based lymphatic filariasis education in Orissa State, India, increased treatment compliance from around 50% to up to 90%, according to a study published June 29 in the open-access journal PLoS Neglected Tropical Diseases. In their study, researchers from the U.S. Centers for Disease Control and Prevention, in partnership with the Church's Auxiliary for Social Action, an India-based non-governmental organization, and IMA World Health, a US-based non-governmental organization, identified barriers to compliance with India's MDA program for LF, and suggest that timely educational and lymphedema management programs can reverse this trend.

1 Jul 2010

Latest health disparity report examines trend of higher tobacco use among LGBT community

The American Lung Association's latest health disparity report, Smoking Out a Deadly Threat: Tobacco Use in the LGBT Community, examines the trend of higher tobacco use among the lesbian, gay, bisexual and transgender community and the need for additional research specific to this community.

1 Jul 2010

Varian, Brainlab expand partnership to incorporate Novalis technology with TrueBeam STx system

Varian Medical Systems and Brainlab today announced the expansion of their partnership to incorporate Novalis technology and other Novalis Radiosurgery Program elements with the recently launched TrueBeam STx system. The expanded suite of products will be badged "Novalis powered by TrueBeam STx."

1 Jul 2010

Constituents of the U.S. healthcare system ready to adopt value-based insurance designs: Study

A new study commissioned by The TriZetto Group, Inc. finds that doctors, health insurers, consumers and other constituents of the U.S. healthcare system say they are ready and willing to adopt value-based insurance designs and related payment programs. Such designs encourage patients and clinicians to make better choices to improve care based on proven best practices, using both better information and financial incentives.

1 Jul 2010

Medical News

Commonly used type of bone marrow stem cell may help treat sepsis, new study suggests

Highly specific assay developed to detect ERG alterations in prostate cancer

Celsis IVT files patent infringement lawsuit against Invitrogen, CellzDirect

FnBP is central to bacteria's ability to invade organs: Researchers

Mass. reports on people who buy insurance only when sick; Wash. board considers aiding consumers get 'Plan B' referrals; ACLU sues R.I. over electronic records

PIKAMAB secures exclusive rights to issued U.S. patent from UABRF

New research identifies memory and brain scan as best tests for predicting Alzheimer's disease

Secondhand smoke exposure during pregnancy causes permanent genetic damage in newborns

Twelve residents receive one-year fellowship grant to study medical dermatology

Endo responds to FDA Complete Response letter for FORTESTA NDA

Eisai to commercialize lorcaserin for obesity and weight management in U.S.

Advancements in total hip replacement procedure make young patients opt for surgery

New guide to get pregnant

Women in early recovery gain new perspective on helping themselves by helping others

Gore receives European CE Mark approval for 25 cm GORE VIABAHN Endoprosthesis

Eisai signs agreement with Arena Pharmaceuticals GmbH to commercialize lorcaserin

Community-based lymphatic filariasis education increases treatment compliance up to 90%: Study

Latest health disparity report examines trend of higher tobacco use among LGBT community

Varian, Brainlab expand partnership to incorporate Novalis technology with TrueBeam STx system

Constituents of the U.S. healthcare system ready to adopt value-based insurance designs: Study

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News